The focus is not just on treatment, but on helping people understand why a specific option fits their needs
Ingredients: saffower oil (conjugated linoleic acid 80%), green tea extract (50% polyphenols), L-carnitine, capsule [Medium-chain triglyceride (filling agent), gelatin (with 12% water), humectant (glycerol), lecithin (emulsifier), beeswax (stabilizer), red iron oxide (colour)]
The practical effect is that biosimilar developers operate with substantially less pre-investment visibility into patent risk than their generic drug counterparts a key reason why the biosimilar market has matured more slowly than the generic drug market despite being launched with similar policy intent
In findings from a phase 2a trial that were presented at the American Diabetes Association Scientific Sessions and simultaneously published in The Lancet , 71% of adults receiving coadministered cagrilintide and semaglutide 2.4 mg, dubbed CagriSema (Novo Nordisk), lost at least 10% of their body weight, and 89% of adults achieved an HbA1c of less than 7% with the combination therapy
